Cargando…
COVID-19 Prevention in Solid Organ Transplant Recipients: Current State of the Evidence
Although COVID-19 vaccines are safe, most organ transplant recipients fail to mount an antibody response after two mRNA vaccines. Thus, three mRNA vaccines constitute a primary vaccine series after solid organ transplant. However, neutralizing antibodies after three or greater mRNA vaccines are lowe...
Autores principales: | Vafea, Maria Tsikala, Haidar, Ghady |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030334/ https://www.ncbi.nlm.nih.gov/pubmed/37217369 http://dx.doi.org/10.1016/j.idc.2023.03.002 |
Ejemplares similares
-
Immunity to a third BNT162B2 COVID-19 vaccine after heart transplantation: Bridging the knowledge gap to end the pandemic for organ transplant recipients
por: Haidar, Ghady
Publicado: (2022) -
Diagnostic Modalities for Invasive Mould Infections among Hematopoietic Stem Cell Transplant and Solid Organ Recipients: Performance Characteristics and Practical Roles in the Clinic
por: Haidar, Ghady, et al.
Publicado: (2015) -
THU322 Lower HbA1c Is Associated With Lower In-Hospital Mortality In Patients With COVID-19
por: Tsikala Vafea, Maria, et al.
Publicado: (2023) -
Coronavirus Disease 2019 (COVID-19), Organ Transplantation, and the Nuances of Immunomodulation: Lessons Learned and What Comes Next
por: Haidar, Ghady
Publicado: (2020) -
COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature
por: Heldman, Madeleine R., et al.
Publicado: (2021)